 efficaci fludarabin new adenin analogu patient prolymphocyt leukemia prolymphocytoid variant chronic lymphocyt leukemia purpos result fludarabin therapi patient prolymphocyt leukemia pll prolymphocytoid variant chronic lymphocyt leukemia cll-pro patient method seventeen patient diagnosi pll cll-pro fludarabin minut day week patient prednison patient criteria respons differ respons rate variou characterist chi-squar test result patient complet remiss partial remiss overal respons rate respons durabl organ site respons rate patient anemia thrombocytopenia rai stage primari resist therapi toxic minim febril episod therapi conclus fludarabin encourag result patient investig combin activ agent set front-lin therapi